This inventor holds 1 USPTO granted patent. Top assignee: Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: Mariko Shimamura: Innovator in Pharmaceutical Composition
Introduction
Mariko Shimamura is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the area of angiogenesis inhibition. Her work is crucial for developing therapeutic agents that can help manage conditions such as diabetic retinopathy.
Latest Patents
Mariko holds a patent for a pharmaceutical composition and method for angiogenesis inhibition. The patent describes Actinonin or a salt thereof as an active inhibitor of angiogenesis in mammals. This invention is particularly useful as a therapeutic agent for inhibiting angiogenesis in mammals suffering from diabetic retinopathy or inflammatory responses accompanied by angiogenesis. She has 1 patent to her name.
Career Highlights
Mariko is associated with the organization Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai, where she continues her research and development efforts. Her innovative work has positioned her as a key figure in the pharmaceutical industry.
Collaborations
Mariko has collaborated with notable colleagues, including Takao Iwaguchi and Shingo Uchida. These partnerships have further enhanced her research capabilities and contributed to her success in the field.
Conclusion
Mariko Shimamura's contributions to pharmaceutical innovation, particularly in angiogenesis inhibition, highlight her importance as an inventor. Her work continues to pave the way for advancements in therapeutic treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile